Skip to content
10-Q

Quarterly Report

SCPHARMACEUTICALS INC.

0001193125-25-175437

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 53.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 53.72M sh
Shares Diluted Q2 2025 · Jun 30, 2025 53.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 38.98M sh
Shares Diluted Q2 2025 · Jun 30, 2024 38.97M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$33.25M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$37.93M
Long Term Debt Q2 2025 · Jun 30, 2025 $51.2M
Long Term Debt Q2 2025 · Dec 31, 2024 $51.35M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $40.81M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $75.66M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$21.32M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$5.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 $13.32M
Stockholders Equity Q2 2025 · Jun 30, 2024 $9.25M
Stockholders Equity Q2 2025 · Mar 31, 2024 $24.57M
Stockholders Equity Q2 2025 · Dec 31, 2023 $37.22M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.43M
Current Liabilities Q2 2025 · Dec 31, 2024 $14.88M
Total Liabilities Q2 2025 · Jun 30, 2025 $101.57M
Total Liabilities Q2 2025 · Dec 31, 2024 $94.2M
Current Assets Q2 2025 · Jun 30, 2025 $78.73M
Current Assets Q2 2025 · Dec 31, 2024 $105.85M
Total Assets Q2 2025 · Jun 30, 2025 $80.26M
Total Assets Q2 2025 · Dec 31, 2024 $107.52M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.70
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.44
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.80
Eps Basic Q2 2025 · Jun 30, 2025 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.70
Eps Basic Q2 2025 · Jun 30, 2024 −$0.44
Eps Basic Q2 2025 · Jun 30, 2024 −$0.80
Sga Expense Q2 2025 · Jun 30, 2025 $21.23M
Sga Expense Q2 2025 · Jun 30, 2025 $42.63M
Sga Expense Q2 2025 · Jun 30, 2024 $17.51M
Sga Expense Q2 2025 · Jun 30, 2024 $34.96M
Rd Expense Q2 2025 · Jun 30, 2025 $4.1M
Rd Expense Q2 2025 · Jun 30, 2025 $8.73M
Rd Expense Q2 2025 · Jun 30, 2024 $2.68M
Rd Expense Q2 2025 · Jun 30, 2024 $5.4M
Net Income Q2 2025 · Jun 30, 2025 −$18.02M
Net Income Q2 2025 · Jun 30, 2025 −$37.77M
Net Income Q2 2025 · Jun 30, 2024 −$17.09M
Net Income Q2 2025 · Jun 30, 2024 −$31.2M
Operating Income Q2 2025 · Jun 30, 2025 −$14.29M
Operating Income Q2 2025 · Jun 30, 2025 −$32.05M
Operating Income Q2 2025 · Jun 30, 2024 −$14.43M
Operating Income Q2 2025 · Jun 30, 2024 −$30.29M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.01M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $8.48M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.3M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $4.09M
Revenue Q2 2025 · Jun 30, 2025 $16.04M
Revenue Q2 2025 · Jun 30, 2025 $27.79M
Revenue Q2 2025 · Jun 30, 2024 $8.05M
Revenue Q2 2025 · Jun 30, 2024 $14.16M